SDGR
Schrödinger, Inc. NASDAQ Listed Feb 6, 2020$13.28
Mkt Cap $992.3M
52w Low $10.95
14.0% of range
52w High $27.63
50d MA $12.10
200d MA $16.73
P/E (TTM)
-8.8x
EV/EBITDA
-12.4x
P/B
2.5x
Debt/Equity
0.3x
ROE
-28.4%
P/FCF
105.4x
RSI (14)
—
ATR (14)
—
Beta
1.62
50d MA
$12.10
200d MA
$16.73
Avg Volume
1.7M
Schrödinger, Inc., together with its subsidiaries, provides physics-based software platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on selling its software for drug discovery in the life sciences industry, as well as to customers in materials science industries. The Drug Discovery segment focuses on building a portfolio of preclinical and clinical programs, internally and through collaborations. The company serves biopharmaceutical and industrial companies, academic institutions, and government laboratories worldwide. Schrödinger, Inc. was incorporated in 1990 and is based in New York, New York.
1540 Broadway · New York City, NY 10036 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 5, 2026 | AMC | -0.56 | -0.81 | -44.6% | 12.87 | -5.4% | +0.9% | +2.3% | — | — | — | — |
| Feb 25, 2026 | AMC | -0.13 | 0.44 | +438.5% | 11.80 | +10.2% | +8.1% | -5.5% | +0.7% | +2.9% | +5.0% | — |
| Nov 5, 2025 | AMC | -0.75 | -0.45 | +40.0% | 19.77 | -2.3% | -5.7% | -4.7% | +2.9% | +0.1% | -1.7% | — |
| Aug 6, 2025 | AMC | -0.83 | -0.59 | +28.9% | 19.34 | +5.0% | +0.1% | -0.8% | -3.0% | +1.2% | +5.3% | — |
| May 7, 2025 | AMC | -0.71 | -0.82 | -15.5% | 23.72 | +3.2% | +0.7% | +0.1% | +1.1% | -1.7% | +0.7% | — |
| Feb 26, 2025 | AMC | -0.35 | -0.55 | -57.1% | 21.70 | +1.4% | +2.5% | +0.3% | -4.8% | -0.8% | +3.6% | — |
| Nov 12, 2024 | AMC | -0.60 | -0.52 | +13.3% | 22.25 | -0.9% | -0.7% | -7.8% | -9.0% | -1.7% | +3.8% | — |
| Jul 31, 2024 | AMC | -0.85 | -0.74 | +12.9% | 22.28 | +9.2% | +1.4% | -10.4% | -6.0% | +0.9% | -5.9% | — |
| May 1, 2024 | AMC | -0.75 | -0.76 | -1.3% | 25.26 | -9.3% | -8.2% | +2.1% | +1.6% | -1.4% | -2.1% | — |
| Feb 28, 2024 | AMC | -0.38 | -0.41 | -7.9% | 31.37 | -14.3% | -18.8% | +5.3% | -5.9% | -2.0% | +0.3% | — |
| Nov 1, 2023 | AMC | -0.71 | -0.86 | -21.1% | 21.82 | +7.7% | +14.7% | +13.3% | -2.4% | +2.3% | -3.8% | — |
| Aug 2, 2023 | AMC | -0.43 | -0.21 | +51.2% | 50.24 | -21.3% | -23.9% | +4.0% | -4.3% | +1.2% | +3.6% | — |
| May 4, 2023 | AMC | 1.36 | -0.38 | -127.9% | 30.12 | -2.8% | -8.1% | +0.3% | -1.7% | +2.4% | -5.0% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 8 | KeyBanc Capital Markets | Maintains | Overweight → Overweight | — | $11.39 | $11.97 | +5.1% | +1.0% | -0.3% | -0.9% | +0.7% | +4.0% |
| Mar 17 | UBS | Maintains | Neutral → Neutral | — | $12.70 | $12.55 | -1.2% | -3.2% | -2.5% | +1.8% | -1.5% | -1.2% |
| Jan 8 | TD Cowen | Maintains | Buy → Buy | — | $18.77 | $18.71 | -0.3% | -0.9% | -1.2% | +1.4% | -1.8% | +0.1% |
| Jan 8 | KeyBanc Capital Markets | Maintains | Overweight → Overweight | — | $18.77 | $18.71 | -0.3% | -0.9% | -1.2% | +1.4% | -1.8% | +0.1% |
| Dec 15 | BofA Securities | Upgrade | Neutral → Buy | — | $18.05 | $18.94 | +4.9% | +0.9% | -1.5% | -3.0% | -1.1% | +2.7% |
| Oct 8 | KeyBanc Capital Markets | Maintains | Overweight → Overweight | — | $20.16 | $20.21 | +0.2% | +2.8% | -0.3% | -7.6% | +3.2% | -1.4% |
| Aug 18 | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | $19.38 | $19.38 | +0.0% | +3.5% | -3.2% | -0.2% | +1.1% | +3.8% |
| Aug 15 | Citigroup | Downgrade | Buy → Neutral | — | $19.45 | $18.67 | -4.0% | -0.4% | +3.5% | -3.2% | -0.2% | +1.1% |
| Jul 14 | KeyBanc Capital Markets | Maintains | Overweight → Overweight | — | $21.01 | $20.81 | -1.0% | +0.6% | -3.6% | +4.3% | +1.9% | -0.9% |
| Apr 16 | KeyBanc Capital Markets | Maintains | Overweight → Overweight | — | $25.60 | $25.58 | -0.1% | -1.5% | +2.1% | +1.7% | -0.8% | -2.0% |
| Feb 27 | Piper Sandler | Maintains | Overweight → Overweight | — | $21.70 | $22.00 | +1.4% | +2.5% | +0.3% | -4.8% | -0.8% | +3.6% |
| Jan 24 | KeyBanc Capital Markets | Maintains | Overweight → Overweight | — | $24.41 | $24.82 | +1.7% | +1.1% | -2.4% | +6.0% | -2.2% | +1.9% |
| Nov 13 | BMO Capital | Maintains | Outperform → Outperform | — | $22.25 | $22.04 | -0.9% | -0.7% | -7.8% | -9.0% | -1.7% | +3.8% |
| Oct 17 | BMO Capital | Maintains | Outperform → Outperform | — | $17.92 | $17.78 | -0.8% | -1.8% | +1.2% | +0.7% | +4.2% | -3.0% |
| Aug 21 | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | $20.48 | $20.44 | -0.2% | -1.9% | -3.0% | +1.9% | +4.9% | -1.1% |
| Jul 11 | KeyBanc Capital Markets | Maintains | Overweight → Overweight | — | $20.58 | $21.27 | +3.4% | +4.8% | +3.9% | +1.3% | +5.9% | -3.5% |
| May 2 | Citigroup | Maintains | Buy → Buy | — | $25.26 | $22.90 | -9.3% | -8.2% | +2.1% | +1.6% | -1.4% | -2.1% |
| May 2 | Craig-Hallum | Maintains | Buy → Buy | — | $25.26 | $22.90 | -9.3% | -8.2% | +2.1% | +1.6% | -1.4% | -2.1% |
| Mar 1 | Citigroup | Maintains | Buy → Buy | — | $25.46 | $25.53 | +0.3% | +5.3% | -5.9% | -2.0% | +0.3% | +8.0% |
| Mar 1 | Goldman Sachs | Maintains | Neutral → Neutral | — | $25.46 | $25.53 | +0.3% | +5.3% | -5.9% | -2.0% | +0.3% | +8.0% |
| Feb 29 | BofA Securities | Maintains | Neutral → Neutral | — | $31.37 | $26.89 | -14.3% | -18.8% | +5.3% | -5.9% | -2.0% | +0.3% |
| Feb 29 | Piper Sandler | Maintains | Overweight → Overweight | — | $31.37 | $26.89 | -14.3% | -18.8% | +5.3% | -5.9% | -2.0% | +0.3% |
| Feb 29 | KeyBanc Capital Markets | Maintains | Overweight → Overweight | — | $31.37 | $26.89 | -14.3% | -18.8% | +5.3% | -5.9% | -2.0% | +0.3% |
| Feb 29 | Citigroup | Maintains | Buy → Buy | — | $31.37 | $26.89 | -14.3% | -18.8% | +5.3% | -5.9% | -2.0% | +0.3% |
| Jan 19 | Craig-Hallum | Maintains | Buy → Buy | — | $25.98 | $26.05 | +0.3% | +1.5% | +3.8% | -0.4% | -0.5% | -1.1% |
| Nov 13 | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | $27.33 | $27.00 | -1.2% | +1.6% | +8.9% | +2.1% | +0.0% | -0.1% |
| Aug 4 | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | $38.23 | $38.51 | +0.7% | +4.0% | -4.3% | +1.2% | +3.6% | -4.0% |
| Aug 3 | BMO Capital | Maintains | Outperform → Outperform | — | $50.24 | $39.54 | -21.3% | -23.9% | +4.0% | -4.3% | +1.2% | +3.6% |
| Jun 29 | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | $44.79 | $45.50 | +1.6% | +6.3% | +4.9% | -2.5% | +1.4% | -4.4% |
| May 8 | Citigroup | Maintains | Buy → Buy | — | $27.67 | $27.54 | -0.5% | +0.3% | -1.7% | +2.4% | -5.0% | -1.6% |
| Mar 10 | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | $24.81 | $24.68 | -0.5% | -5.4% | +3.6% | +5.3% | +0.5% | +3.5% |
| Mar 1 | BMO Capital | Maintains | Outperform → Outperform | — | $21.73 | $26.67 | +22.7% | +13.2% | -0.9% | +7.3% | -4.0% | +0.7% |
| Jan 31 | Citigroup | Maintains | Buy → Buy | — | $22.05 | $22.48 | +2.0% | +9.7% | +4.0% | +9.8% | -5.4% | -2.6% |
| Jan 19 | Piper Sandler | Maintains | Overweight → Overweight | — | $23.81 | $23.12 | -2.9% | -0.2% | -2.8% | +3.0% | -4.7% | +1.3% |
| Nov 4 | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | $24.66 | $24.08 | -2.4% | -15.2% | -1.5% | +0.3% | -3.1% | +8.3% |
| Nov 4 | BMO Capital | Maintains | Outperform → Outperform | — | $24.66 | $24.08 | -2.4% | -15.2% | -1.5% | +0.3% | -3.1% | +8.3% |
| Sep 9 | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | $28.39 | $28.93 | +1.9% | -1.2% | +2.6% | -2.1% | +2.8% | -0.1% |
| Aug 24 | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | $28.19 | $28.06 | -0.5% | +1.0% | +1.4% | -4.1% | -2.1% | -0.6% |
| Jul 26 | Piper Sandler | Maintains | Overweight → Overweight | — | $31.54 | $31.78 | +0.8% | -0.1% | +2.1% | -0.1% | -2.6% | -1.4% |
| May 5 | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | $26.88 | $26.07 | -3.0% | -8.2% | +1.5% | -6.7% | -0.3% | -8.2% |
| Mar 1 | Citigroup | Maintains | Buy → Buy | — | $34.76 | $35.46 | +2.0% | +3.9% | -1.7% | -5.5% | -3.9% | -4.9% |
| Nov 19 | Piper Sandler | Maintains | Overweight → Overweight | — | $41.66 | $41.25 | -1.0% | -2.1% | -6.1% | -0.2% | +2.7% | +0.6% |
| Nov 19 | Morgan Stanley | Downgrade | Overweight → Equal Weight | — | $41.66 | $41.25 | -1.0% | -2.1% | -6.1% | -0.2% | +2.7% | +0.6% |
| Nov 11 | BofA Securities | Downgrade | Buy → Neutral | — | $51.16 | $47.07 | -8.0% | -11.7% | +4.3% | -3.5% | +0.2% | -2.4% |
| Oct 13 | Berenberg | Maintains | Buy → Buy | — | $51.37 | $52.59 | +2.4% | +5.1% | +1.9% | +0.6% | -3.8% | +4.6% |
| Sep 1 | Morgan Stanley | Upgrade | Equal Weight → Overweight | — | $59.69 | $62.17 | +4.2% | +5.1% | +3.0% | +1.0% | -3.6% | +0.3% |
| May 25 | Craig-Hallum | Maintains | Buy → Buy | — | $65.36 | $66.63 | +1.9% | +4.7% | +3.6% | +0.5% | -1.4% | +1.9% |
| May 12 | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | $61.74 | $61.01 | -1.2% | -3.3% | -1.1% | +3.8% | +0.3% | +3.2% |
| Nov 23 | BofA Securities | Upgrade | Neutral → Buy | — | $60.60 | $64.86 | +7.0% | +11.6% | -2.2% | -3.9% | +9.4% | -0.0% |
| Nov 13 | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | $52.69 | $53.57 | +1.7% | +9.7% | +1.7% | +1.3% | -3.0% | +1.4% |
No insider trades available.
8-K · 5.02
!!! Very High
Unknown — 8-K 5.02: Executive Change
A new executive appointment at Sandridge Energy without conflicting interests suggests smooth leadership transition, but investors should monitor whether this change affects strategic direction or operational execution.
Mar 12
8-K
Schrodinger, Inc. -- 8-K Filing
Schrödinger achieved $256 million total revenue in 2025 with $200 million from software, demonstrating accelerating transition to recurring revenue while targeting positive adjusted EBITDA by 2028.
Feb 25
Data updated apr 27, 2026 12:33am
· Source: massive.com